WHO and many national health authorities neglected scientific evidence from the beginning

28.01.2010: It seems, that the World Health Organisation (WHO) followed other logic than that of scientific evidence in public health.

A one-sided molecular view and dominating veterinary influence have obviously shaped the threatening fictive model of some future pandemic for the WHO.

But can we exclude, that this agenda setting has not just been created under sponsorship of clever marketing specialists of the Big Pharma, instrumentalising WHO's public-private health partnerships for their shareholders?

Here some important facts by the senior WHO epidemiologist James Chin, who enlightens the background of the WHO's pandemic alarm. His statements were part of an article in "Los Angeles Times", written by Michael Fumento and published on the 14th of June 2009, three days after WHO General Secretary Margaret Chan declared level 6 of a global "pandemic": fumento.com/swineflu/who.html

WHO just seems to have disregarded all critics, lots of information and a big amount of arguments and evidence existing and being published.

General secretary Margaret Chan is responsible for inducing a media driven campaign, fostering panic and irrational fears to rise the public willingness to take a vaccine all over the globe.

And here a recent review by Michael Fumento on the same topic

Here another document prooving the ignorance of WHO and its tendency to follow pharma interests:

  • Seite bei Twitter teilen
  • Seite bei Facebook teilen
  • Seite bei StudiVZ teilen
  • Seite bei MySpace teilen
  • Seite bei Mister Wong bookmarken
  • Seite bei del.icio.us bookmarken
  • Seite bei Google bookmarken
  • Seite bei Live bookmarken
  • Seite bei YahooMyWeb bookmarken
Zum Thema
  • EU negotiates in India on behalf of Big Pharma and trades away Access to Medicines10.02.2011 | An alarming blog by Els Torreele, the Director of the Access to Essential Medicines Initiative of the Open Society Public Health Program:
    Recent news reports on negotiations between India and the European Union on a proposed free trade agreement (FTA) have many health and human rights experts worried that millions of people may be left without access to life-saving medicines. Indeed people in low-resource countries are critically dependent on affordable medicines produced by India, which for that reason has been dubbed the “pharmacy of the developing world.” If, as reports indicate, EU negotiators succeed in pressuring India to beef up intellectual property protection at the expense of public access rights for life-saving drugs, the FTA would seriously undercut India’s ability to produce generic, low-cost drugs, with detrimental effects on access to medicines for the developing world. mehr »